Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites.
Alzheimer's disease (AD) is the most common form of dementia. It affects approximately 6% of people over the age of 65 years. It is a clinicopathological, degenerative, chronical and progressive disease that exhibits a deterioration of memory, orientation, speech and other functions. Factors contrib...
| Publicado en: | Critical Reviews in Clinical Laboratory Sciences Vol. 58; no. 3; pp. 167 - 180 |
|---|---|
| Autores principales: | , , , |
| Formato: | pictorial review tables/charts Journal Article |
| Publicado: |
Taylor & Francis Ltd
May2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |